Paragon 28 (NYSE:FNA) Given Hold Rating at Canaccord Genuity Group

Paragon 28 (NYSE:FNA)‘s stock had its “hold” rating reaffirmed by research analysts at Canaccord Genuity Group in a note issued to investors on Wednesday,Benzinga reports.

A number of other research analysts have also recently issued reports on FNA. Stephens upgraded Paragon 28 to a “strong-buy” rating in a research report on Monday, December 2nd. Needham & Company LLC reissued a “hold” rating and issued a $13.00 price objective on shares of Paragon 28 in a research note on Wednesday. Finally, William Blair cut shares of Paragon 28 from an “outperform” rating to a “market perform” rating in a research note on Wednesday. Three analysts have rated the stock with a hold rating, two have assigned a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $15.60.

Paragon 28 Price Performance

Shares of NYSE:FNA traded up $1.00 during trading on Wednesday, reaching $13.00. 20,918,508 shares of the company traded hands, compared to its average volume of 1,648,896. The firm has a market capitalization of $1.09 billion, a PE ratio of -17.56 and a beta of 1.50. Paragon 28 has a 52 week low of $4.65 and a 52 week high of $14.79. The company has a quick ratio of 1.60, a current ratio of 3.50 and a debt-to-equity ratio of 0.79. The company’s 50 day moving average is $10.48 and its two-hundred day moving average is $8.35.

Paragon 28 (NYSE:FNA) last issued its quarterly earnings results on Tuesday, November 12th. The company reported ($0.15) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.16) by $0.01. Paragon 28 had a negative net margin of 25.31% and a negative return on equity of 37.90%. The company had revenue of $62.30 million during the quarter, compared to the consensus estimate of $60.58 million. During the same quarter in the prior year, the firm posted ($0.10) EPS. The firm’s quarterly revenue was up 18.0% on a year-over-year basis. As a group, sell-side analysts predict that Paragon 28 will post -0.64 earnings per share for the current year.

Insider Transactions at Paragon 28

In other Paragon 28 news, major shareholder Mvm Partners, Llc sold 147,581 shares of Paragon 28 stock in a transaction on Wednesday, November 20th. The shares were sold at an average price of $10.28, for a total value of $1,517,132.68. Following the completion of the sale, the insider now directly owns 10,738,564 shares of the company’s stock, valued at approximately $110,392,437.92. The trade was a 1.36 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Insiders sold a total of 273,050 shares of company stock worth $2,819,696 over the last three months. 15.32% of the stock is owned by company insiders.

Institutional Trading of Paragon 28

Several large investors have recently made changes to their positions in FNA. Renaissance Technologies LLC bought a new stake in shares of Paragon 28 during the second quarter worth about $419,000. Hsbc Holdings PLC bought a new position in shares of Paragon 28 in the second quarter valued at approximately $104,000. Sei Investments Co. purchased a new position in shares of Paragon 28 during the second quarter valued at approximately $531,000. Cubist Systematic Strategies LLC bought a new stake in Paragon 28 during the second quarter worth $869,000. Finally, Squarepoint Ops LLC raised its position in Paragon 28 by 87.9% in the 2nd quarter. Squarepoint Ops LLC now owns 129,576 shares of the company’s stock valued at $886,000 after buying an additional 60,628 shares during the last quarter. 63.57% of the stock is currently owned by institutional investors and hedge funds.

Paragon 28 Company Profile

Paragon 28, Inc develops, distributes, and sells foot and ankle surgical systems in the United States and internationally. It offers plating systems, including gorilla plating systems, such as lisfranc, lapidus, lateral column, calcaneus slide, and naviculocuneiform (NC) fusion plating systems; baby gorilla plate-specific screws, navicular fracture plates, and 5th metatarsal hook plates; and silverback plating systems.